Understanding immune responses to emerging viruses for better vaccines
Official title: Virologic and Immunologic Sample Acquisition Core
Funded at Vanderbilt University Medical Center · NIH-10863658 · Data updated 2026-11-12
This study is looking for people to help us understand how our immune system reacts to new viruses by giving blood samples, which could lead to better vaccines and treatments for future outbreaks.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project start | August 20, 2024 |
| Project end | July 31, 2027 |
| Funding year | 2024 |
| Award (this year) | $2,410,342 |
| NIH project number | 1U19AI181979-01 |
| Project ID | NIH-10863658 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates include individuals of all ages who have been exposed to specific pathogens or are part of diverse populations.
✕Less likely to help
Patients who are not exposed to the targeted pathogens or do not have a diverse immune response may not benefit from this research.
What this research studies
This research focuses on collecting and analyzing blood samples to understand how the human immune system responds to emerging viruses. By evaluating the immune responses, including T and B cell activity, the research aims to identify potential vaccine candidates and therapeutic antibodies. Participants will provide specialized immunologic specimens, which will help in developing strategies to protect against future pandemics. The research is part of a larger initiative to enhance preparedness for viral outbreaks.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective vaccines and treatments for emerging viral infections.
How similar studies have gone: Previous research has shown success in using similar approaches to develop vaccines and therapeutics against emerging infectious diseases.
Where this research is happening
-
Vanderbilt University Medical Center
Nashville, United States Active
Researchers
- Principal investigator: Kimberlin, David W — Vanderbilt University Medical Center
- Study coordinator: Kimberlin, David W
Related research
Other NIH-funded projects on the same topics.
-
Improving healthcare for patients with inherited cancer syndromes using a web-based platform
This study is testing a new online tool called MeTree that helps people understand their risk for inherited cancer by combining their medical records and family health history, making it easier for patients and doctors to get the information they need for better care and support.
-
Stroke prevention with hydroxyurea for children with sickle cell anemia in Nigeria
A multinational, patient-facing study tests whether hydroxyurea can safely prevent first strokes in Nigerian children with sickle cell anemia.
-
Scaling Up Task-Shifted Epilepsy Care for Children in Africa
A study to help children with epilepsy in Africa get diagnosed and receive seizure care through trained community health workers.
-
Enhanced surveillance for new vaccine‑preventable diseases
A Vanderbilt team is tracking how well vaccines work and how diseases like flu, RSV, norovirus, and SARS‑CoV‑2 affect young children over time.
-
Generative AI to create private, fair health data for research
A researcher at Vanderbilt aims to use Generative AI to create synthetic health data that protects patient privacy while helping AI models be fairer and more accurate.
-
ConProject-003: A patient-facing initiative at Vanderbilt for advancing care
A Vanderbilt-led project (ConProject-003) is funded to drive improvements in care for people with a specific health condition through a dedicated program.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.